These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of progestogen for women with threatened miscarriage: a systematic review and meta-analysis. Li L; Zhang Y; Tan H; Bai Y; Fang F; Faramand A; Chong W; Hai Y BJOG; 2020 Aug; 127(9):1055-1063. PubMed ID: 32324957 [TBL] [Abstract][Full Text] [Related]
9. Human chorionic gonadotrophin for threatened miscarriage. Devaseelan P; Fogarty PP; Regan L Cochrane Database Syst Rev; 2010 May; (5):CD007422. PubMed ID: 20464754 [TBL] [Abstract][Full Text] [Related]
10. Chinese herbal medicines for threatened miscarriage. Li L; Dou L; Leung PC; Wang CC Cochrane Database Syst Rev; 2012 May; 2012(5):CD008510. PubMed ID: 22592730 [TBL] [Abstract][Full Text] [Related]
11. Progestogens in women with threatened miscarriage or recurrent miscarriage: A meta-analysis. Zhao Y; D'Souza R; Gao Y; Hao Q; Kallas-Silva L; Steen JP; Guyatt G Acta Obstet Gynecol Scand; 2024 Sep; 103(9):1689-1701. PubMed ID: 38481031 [TBL] [Abstract][Full Text] [Related]
12. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Coomarasamy A; Devall AJ; Brosens JJ; Quenby S; Stephenson MD; Sierra S; Christiansen OB; Small R; Brewin J; Roberts TE; Dhillon-Smith R; Harb H; Noordali H; Papadopoulou A; Eapen A; Prior M; Di Renzo GC; Hinshaw K; Mol BW; Lumsden MA; Khalaf Y; Shennan A; Goddijn M; van Wely M; Al-Memar M; Bennett P; Bourne T; Rai R; Regan L; Gallos ID Am J Obstet Gynecol; 2020 Aug; 223(2):167-176. PubMed ID: 32008730 [TBL] [Abstract][Full Text] [Related]
13. A pairwise and network meta-analysis comparing the efficacy and safety of progestogens in threatened abortion. Zhao H; He W; Yang Z Int J Gynaecol Obstet; 2022 Mar; 156(3):383-393. PubMed ID: 33864694 [TBL] [Abstract][Full Text] [Related]
14. Progestogens and pregnancy loss. Carp HJA Climacteric; 2018 Aug; 21(4):380-384. PubMed ID: 29565684 [TBL] [Abstract][Full Text] [Related]
15. Real-world pharmacological treatment patterns of patients with threatened miscarriage in China from 2014 to 2020: A cross-sectional analysis. Pang YY; Ma CL J Clin Pharm Ther; 2022 Feb; 47(2):228-236. PubMed ID: 34704273 [TBL] [Abstract][Full Text] [Related]
16. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial. Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of progesterone on threatened miscarriage: Difference in drug types. Wang XX; Luo Q; Bai WP J Obstet Gynaecol Res; 2019 Apr; 45(4):794-802. PubMed ID: 30632226 [TBL] [Abstract][Full Text] [Related]
18. Sporadic pregnancy loss and recurrent miscarriage. Devall AJ; Coomarasamy A Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():30-39. PubMed ID: 32978069 [TBL] [Abstract][Full Text] [Related]
19. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of progesterone on threatened miscarriage: an updated meta-analysis of randomized trials. Yan Y; Chen Z; Yang Y; Zheng X; Zou M; Cheng G; Yuan Z Arch Gynecol Obstet; 2021 Jan; 303(1):27-36. PubMed ID: 32989508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]